Updated: Lilly details mid-stage win for tirzepatide in MASH with fibrosis data

Eli Lilly has unveiled fibrosis results from a Phase 2 test of tirzepatide in patients with metabolic dysfunction-associated steatohepatitis, or MASH, which could help further …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Who Is at Risk of Caffeine Intoxication?

Welcome to Culture Clinic, MedPage Today‘s collaboration with Northwell Health to offer a healthcare professional’s take on the latest viral medical topics. While caffeine —

March 15, 2024

Emicizumab Can Delay Immunosuppressive Tx in Acquired Hemophilia A

Early emicizumab (Hemlibra) prophylaxis alone prevented clinically relevant bleeds in patients with newly diagnosed acquired hemophilia A, while avoiding the infectious complications of immunosuppressive therapy

October 19, 2023

New method for detecting and treating breast cancer subtypes

The most prevalent disease in women, breast cancer, poses a major risk to the health of women.

April 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.